VVT Medical Ltd

28/11/2024

05/11/2024

on Dr. Sasko Nikolov from North Macedonia, who specializes in Interventional Cardiology and has performed a few dozen cases of ScleroSafe in the past few months. "ScleroSafe is my preferred technology for treating varicose veins, particularly in complex cases like ulcers, recurrences, and advanced vein conditions. Its quick and straightforward technique enables me to complete the procedure in minutes, with minimal discomfort and downtime for the patient".
To learn more about ScleroSafe, click: https://www.vvtmed.com/products/the-sclerosafe-platform/
Промедика Медикал Центар

29/08/2024

September is Vascular Awareness Month!
Vascular health is vital to our overall well-being, but conditions like vein insufficiency often go unnoticed until they become more serious. Raising awareness is key—early detection and effective treatment can make all the difference.
That's where ScleroSafe comes in.
As a cutting-edge solution, ScleroSafe offers a safe, effective, and minimally invasive option for treating vein insufficiency.
With a focus on patient comfort and quicker recovery times, ScleroSafe helps more people access the care they need with less risk.
This Vascular Awareness Month, let's spread the word about the importance of vein health. Together, we can help more people lead healthier lives!

09/07/2024

Revolutionizing Vein Insufficiency Treatments in the US: The Rise of NTNT Solutions!

In 2024, we're witnessing a groundbreaking shift in vein insufficiency treatments towards non-thermal, non-tumescent (NTNT) solutions.

NTNT methods like ScleroSafe are setting new standards, offering substantial benefits over traditional Radiofrequency Ablation (RFA) and Endovenous Laser Treatment (EVLT):

✅ No Heat Involved: Minimizes the risk of thermal injury.

✅ No Tumescent Anesthesia: Simplifies procedures and enhances patient comfort.

✅ Quick Recovery: Patients can often return to normal activities almost immediately.

✅ Minimally Invasive: Smaller or no incisions lead to better cosmetic outcomes.

As patient demand for minimally invasive, quick-recovery treatments grows, NTNT solutions are poised to reshape the future of vein insufficiency care.

Let's embrace this new era of advanced, patient-friendly treatments! 💡

To schedule a demo in the US: https://sclerosafeus.com/contact-us/

20/06/2024

Last week at the conference, Dr. Felipe Mamprin from the Centro Clinico Mamprin in Sao Paulo successfully performed a live procedure. Hundreds of venous physicians from and across Latin America observed this live case, which was complemented by interactive sessions during the procedure and after. We're excited to see this significant market expanding as physicians seek advanced solutions to tackle the widespread issue of varicose veins!

21/04/2024

Check out our new 3-D animated video of the ScleroSafe Mechano-Chemical technology!!
https://youtu.be/iGT0Q9Qgps4

ScleroSafe procedure has never been clearer to understand!Watch now to learn about the ScleroSafe mechano-chemical technique!!!

28/09/2023

Dr Igor Rafael Sincos from Brazil explaining the ScleroSafe procedure!

07/08/2023

https://www.vvtmed.com/contact-us/

27/06/2023

on Dr. Alexander Kantarovsky, a certified vascular surgeon specializing in lower limb venous diseases for over 30 years. Here is what he had to say about using 𝗦𝗰𝗹𝗲𝗿𝗼𝗦𝗮𝗳𝗲™ for the treatment of varicose veins:

Dr Kantarovsky shares his positive experience with SclerSafe when treating patients with Varicose Veins

25/06/2023

A new chapter begins as our company 𝘀𝗲𝗰𝘂𝗿𝗲𝘀 𝗙𝗗𝗔 𝟱𝟭𝟬(𝗸) 𝗰𝗹𝗲𝗮𝗿𝗮𝗻𝗰𝗲, paving the way for VVT Medical to reach its goal of treating as many patients with varicose veins as possible. With an eye toward successful commercialization in the USA, we are looking forward to our launch there and welcoming investors to take a closer look at the opportunity.

22/06/2023

We are excited to announce the receipt of a 𝟱𝟭𝟬(𝗸) 𝗙𝗗𝗔 𝗖𝗹𝗲𝗮𝗿𝗮𝗻𝗰𝗲
for the marketing of our 𝗦𝗰𝗹𝗲𝗿𝗼𝗦𝗮𝗳𝗲™ platform in the US!
𝗦𝗰𝗹𝗲𝗿𝗼𝗦𝗮𝗳𝗲™ has already received approval in multiple regions, including Europe, Australia, Southeast Asia, and South America and this achievement marks a very important milestone in our global footprint! https://www.prnewswire.com/news-releases/vvt-medical-receives-fda-510k-clearance-for-its-sclerosafe-system-301857362.html?tc=eml_cleartime